NCT06117891 2026-04-15
REFINE-IO
Bayer
Recruiting
Clinical Trials
3 trialsNCT07298538 2025-12-23
Long-Term Survival With Lenvatinib-Based Therapy in Unresectable Liver Cancer
Tianjin Medical University Cancer Institute and Hospital
Active not recruiting
NCT05660213 2025-05-20
A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer
Fudan University
Not yet recruiting